GlobeNewswire Inc | Sep 9, 2021 08:15AM EDT

September 09, 2021

AUSTIN, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimers disease, announced today that management will present at H.C. Wainwrights 23rd Annual Global Investment Conference, a virtual event that takes place September 13-15, 2021.

Cassava Sciences presentation is a fireside chat with Vernon T. Bernardino, PhD., Managing Director, Biotechnology Equity Research, at H.C. Wainwright.

Event details follow:Date: Monday, September 13^thTime: 7:00 a.m. Eastern TimeWebcast: https://www.CassavaSciences.com/company-presentations

Cassava Sciences fireside chat will be available for replay for 90 days following the conference on www.CassavaSciences.comin the Investors section.

About Alzheimers DiseaseAlzheimers disease is a progressive brain disorder that destroys memory and thinking skills. As of 2020, there were approximately 50 million people worldwide living with dementia, a figure expected to increase to over 150 million by 2050.1 The annual global cost of dementia is now above $1 trillion, according to Alzheimers Disease International, a charitable organization.

About Cassava Sciences, Inc.Cassava Sciences mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimers disease.

Simufilam and SavaDx were both developed in-house. Cassava Sciences owns worldwide development and commercial rights to its research programs in Alzheimers disease, and related technologies, without royalty obligations to any third party.

For more information, please visit https://www.CassavaSciences.com

Contact Information:Eric Schoen, Chief Financial OfficerCassava Sciences, Inc.eschoen@CassavaSciences.com(512) 501-2450

1Alzheimer's Disease International, Dementia Statistics, available on-line and accessed September 8, 2021.